EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$27 |
Appendix 4E, Annual Report and Announcement Date Correction
|
29 Aug 2025 2:49PM |
$0.031 |
$0.036 |
risen by
16.13%
|
|
SkyCity Entertainment Group Limited (SKC) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$662 |
Change in substantial holding
|
29 Aug 2025 2:47PM |
$0.628 |
$0.600 |
fallen by
4.38%
|
|
Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$499 |
Change in substantial holding from MUFG
|
29 Aug 2025 2:47PM |
$2.825 |
$2.540 |
fallen by
10.09%
|
|
Axiom Properties Limited (AXI) ORDINARY FULLY PAID |
Real Estate |
$7 |
Appendix 4G Key to Disclosures
|
29 Aug 2025 2:46PM |
$0.021 |
$0.016 |
fallen by
23.81%
|
|
Heavy Rare Earths Limited (HRE) ORDINARY FULLY PAID |
Materials |
$11 |
Change of Director's Interest Notice X2
|
29 Aug 2025 2:46PM |
$0.049 |
$0.055 |
risen by
12.24%
|
|
Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$9 |
Appendix 4E - Preliminary Final Report
|
29 Aug 2025 2:46PM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
PAB - Price-sensitive ASX Announcement
Full Release
Key Points
- Patrys Limited reported a net loss of $3,013,303 for the financial year ending June 30, 2025, down 14.9% from the previous year.
- The company's cash balance as of June 30, 2025, was $742,441, showing a significant decrease from $2,240,661 the previous year.
- Patrys Limited did not pay, recommend, or declare any dividends during the current or previous financial year.
- The company's research and development expenditure for the year was $1,754,163.
- Net tangible assets per ordinary security were reported at 0.03 cents, down from 0.15 cents the previous year.
- The financial statements are unaudited but are in the process of being audited by BDO Audit Pty Ltd.
- An emphasis of matter regarding material uncertainty in relation to going concern is expected upon audit completion.
- Patrys Limited focuses on the development of novel anti-DNA antibodies for cancer treatment.
- The appendix details significant movements in issued capital and reserves, including share issuances and reallocation of expired and cancelled options.
- The company terminated a licensing agreement with Payload Therapeutics for anti-cancer agents development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$9 |
Appendix 4E - Preliminary Final Report
|
29 Aug 2025 2:46PM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
PAB - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax of $3,013,303, down 14.9% from prior year
- Total other income decreased to $828,540 due to lower R&D tax incentives
- No dividends declared for the current or previous financial year
- Research and development expenditure was $1,754,163
- Cash balance at 30 June 2025 was $742,441
- Net asset position of $732,874
- Share issues and reallocation of expired options conducted
- Auditor expected to note material uncertainty on going concern
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Flagship Investments Limited (FSI) ORDINARY FULLY PAID |
Financials |
$51 |
FSI Appendix 4G 2025
|
29 Aug 2025 2:45PM |
$2.150 |
$1.990 |
fallen by
7.44%
|
|
Flagship Investments Limited (FSI) ORDINARY FULLY PAID |
Financials |
$51 |
Corporate Governance Statement 2025
|
29 Aug 2025 2:45PM |
$2.150 |
$1.990 |
fallen by
7.44%
|
|
Flagship Investments Limited (FSI) ORDINARY FULLY PAID |
Financials |
$51 |
FSI Annual Report to shareholders
|
29 Aug 2025 2:45PM |
$2.150 |
$1.990 |
fallen by
7.44%
|
|
I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$12 |
Half Yearly Report and Accounts
|
29 Aug 2025 2:44PM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
IS3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Net asset deficit of A$1,094,472
- Total comprehensive loss of A$78,949
- Revenue for the half-year at A$378,627
- Basic and diluted loss per share of 0.01 cents
- Loss before taxation of A$57,703
- Issued capital increased through share issuance
- Current and non-current assets and liabilities outlined
- Equity structure and reserves detailed
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$12 |
Half Yearly Report and Accounts
|
29 Aug 2025 2:44PM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
IS3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss reported for the half-year ended 30 June 2025.
- Revenue decreased compared to the previous year.
- Loss before taxation was A$57,703.
- Negative total equity despite issuing additional shares.
- Increase in administrative expenses.
- Foreign currency translation losses impacted comprehensive income.
- Strategic cost management and resource allocation maintained.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
EVZ Limited (EVZ) ORDINARY FULLY PAID |
Industrials |
$21 |
Application for quotation of securities - EVZ
|
29 Aug 2025 2:38PM |
$0.170 |
$0.170 |
fallen by
0%
|
|
Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
H1 FY2025 Results Presentation
|
29 Aug 2025 2:38PM |
$0.018 |
$0.017 |
fallen by
5.56%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue grew by 12.8% YoY to $7.6 million.
- Gross margin increased to 37% from 35%.
- Adjusted EBITDA loss of $2.2 million recorded.
- Operating expenses rose due to acquisitions and closures.
- Cash flow remained neutral with $1.1 million cash balance.
- Focus on e-commerce and innovative launches in H2 FY2025.
- Targeting profitability with optimized operations and new product launches.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
H1 FY2025 Results Presentation
|
29 Aug 2025 2:38PM |
$0.018 |
$0.017 |
fallen by
5.56%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 12.8% YoY to $7.6 million.
- Gross margin improved to 37%, supported by e-commerce.
- Adjusted EBITDA loss widened to $2.2 million.
- Healthy Chef acquisition drove revenue growth.
- Americas segment revenue decreased, focusing on e-commerce.
- Operating cash flow burn reduced, maintaining neutral cash flow.
- Focus on business simplification and profitability in H2 FY2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Lindian Resources Limited (LIN) ORDINARY FULLY PAID |
Materials |
$295 |
Cleansing notice
|
29 Aug 2025 2:37PM |
$0.265 |
$0.220 |
fallen by
16.98%
|
|
Heavy Rare Earths Limited (HRE) ORDINARY FULLY PAID |
Materials |
$11 |
Notification of cessation of securities - HRE
|
29 Aug 2025 2:36PM |
$0.049 |
$0.055 |
risen by
12.24%
|
|
Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
H1 FY2025 Results Announcement
|
29 Aug 2025 2:35PM |
$0.018 |
$0.017 |
fallen by
5.56%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 12.8% YoY to $7.6M.
- Gross margin increased to 37%.
- Operating expenses rose to $5.7M.
- Adjusted EBITDA loss of $2.2M.
- Improved cash discipline reduced outflows to $1.4M.
- Net assets at $7.0M, focusing on working capital reduction.
- Strategic focus on integration and cost rationalization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
H1 FY2025 Results Announcement
|
29 Aug 2025 2:35PM |
$0.018 |
$0.017 |
fallen by
5.56%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 12.8% year-over-year to $7.6 million.
- Adjusted EBITDA loss of $2.2 million.
- Gross margin improved to 37%.
- Operating expenses increased due to acquisitions and facility closures.
- Reduced operating cash outflows, demonstrating improved cash discipline.
- Strategic focus on e-commerce and margin gains.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
H1 FY2025 Results - Appendix 4D
|
29 Aug 2025 2:35PM |
$0.018 |
$0.017 |
fallen by
5.56%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Elixinol recorded a 12.8% revenue growth in H1 FY2025.
- Adjusted EBITDA loss widened to $2,220,000.
- Australian operations remained the primary revenue driver.
- US operations saw reduced marketing activities affecting performance.
- Secured a $1,325,000 debt facility for liquidity support.
- Cash balance on 30 June 2025 was $1,087,000.
- No dividends were declared during H1 FY2025.
- Impairment charges amounted to $288,000.
- The company anticipates a strong second half with new product launches.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
H1 FY2025 Results - Appendix 4D
|
29 Aug 2025 2:35PM |
$0.018 |
$0.017 |
fallen by
5.56%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 12.8% to $7,642,000.
- Loss after tax increased by 12.2% to $3,093,000.
- No dividends were paid or declared.
- Net tangible assets per security decreased to -1.12 cents.
- Increased issued shares and accumulated losses.
- Review report notes use of going concern basis for preparation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Lindian Resources Limited (LIN) ORDINARY FULLY PAID |
Materials |
$295 |
Application for quotation of securities - LIN
|
29 Aug 2025 2:35PM |
$0.265 |
$0.220 |
fallen by
16.98%
|
|
Decidr AI Industries Ltd (DAI) ORDINARY FULLY PAID |
Consumer Staple |
$195 |
Application for quotation of securities - DAI
|
29 Aug 2025 2:34PM |
$0.640 |
$0.940 |
risen by
46.88%
|
|
Vinyl Group Ltd (VNL) ORDINARY FULLY PAID |
Information Technology |
$135 |
Appendix 4G and Corporate Governance Statement
|
29 Aug 2025 2:33PM |
$0.092 |
$0.100 |
risen by
8.70%
|
|
DTI Group Limited (DTI) ORDINARY FULLY PAID |
Information Technology |
$5 |
Preliminary Final Report
|
29 Aug 2025 2:31PM |
$0.008 |
$0.006 |
fallen by
25%
|
|
DTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax for the year was $1,691,731.
- Sales revenue increased to $8,577,909.
- Operational overheads and cost of goods sold impacted profitability.
- Adelaide Metro Operations upgrade is a key project.
- DTI is focusing on expanding global partnerships.
- The company aims for sustainable revenue growth in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.